$1 Trial Offer - Realtime Screener -- Try out our Realtime Product, GetStockIdeas. The advanced screener tool is a momentum trader's dream!

Nektar Therapeutics
(NASDAQ : NKTR)

( )
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Like Small Cap Stocks < $20?
You should, we just banked a 30% winner in 2 days!
100% secure: your email is never shared, and you may opt out at any time.
Loading NKTR News...
...
Health Technology » Biotechnology
symbolcompany%chnglast%shortavg$volume
GILDGilead Sciences, Inc.
0.16%80.211.6%$833.84m
BIIBBiogen Inc.
0.65%308.851.2%$601.02m
AMGNAmgen Inc.
0.59%171.241.0%$515.01m
CELGCelgene Corporation
0.80%108.770.8%$486.82m
MDVNMedivation, Inc.
0.00%80.241.8%$432.24m
REGNRegeneron Pharmaceuticals, Inc.
-0.06%400.003.4%$315.02m
ILMNIllumina, Inc.
0.77%170.794.4%$232.14m
BMRNBioMarin Pharmaceutical Inc.
-0.02%94.963.6%$200.83m
ALXNAlexion Pharmaceuticals, Inc.
0.34%129.612.6%$192.98m
VRTXVertex Pharmaceuticals Incorporated
0.53%96.892.3%$118.62m
INCYIncyte Corporation
1.74%81.492.6%$106.16m
IONSIonis Pharmaceuticals, Inc.
1.07%30.7011.1%$95.21m
AAgilent Technologies, Inc.
0.38%47.440.9%$93.90m
EXASExact Sciences Corporation
0.05%19.0630.9%$93.37m
TSROTESARO, Inc.
0.86%85.9715.8%$88.35m

Company Profile

Nektar Therapeutics is a clinical-stage biopharmaceutical company, which engages in developing drug candidates that utilize its PEGylation and polymer conjugate technology platforms. Its products includes of drug candidates of therapeutic areas, including oncology, pain, anti-infectives, anti-viral, and immunology. It provides small molecule drugs, peptides and other potential biologic drug candidates. It's drug candidates are designed to improve the pharmacokinetics, pharmacodynamics, half-life, bioavailability, metabolism or distribution of drugs and improve the overall benefits and use of a drug for the patient. The company was founded in 1990 and is headquartered in San Francisco, CA.